Código QR (código de barras bidimensional)

A study on the efficacy and Safety Evaluation of a novel PD-1/CTLA-4 bispecific antibody

Tumors constitute a significant health concern for humans, and PD-1 and CTLA-4 monoclonal antibodies have been proven effective in cancer treatment. Some researchers have identified that the combination of PD-1 and CTLA-4 dual blockade demonstrates superior therapeutic efficacy. However, the develop...

ver descrição completa

Na minha lista:
Principais autores: Qi Song, Meiling Jiang, Xinrong Pan, Guanyue Zhou, Xiaomeng Zhang
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2024-11-01
coleção:Immunobiology
Assuntos:
Bispecific antibody
PD-1
CTLA-4
Immunotherapy
Safety
Acesso em linha:http://www.sciencedirect.com/science/article/pii/S0171298524000627
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados